---
layout: default
title: SLAM-AGS: Slide-Label Aware Multi-Task Pretraining Using Adaptive Gradient Surgery in Computational Cytology
---

# SLAM-AGS: Slide-Label Aware Multi-Task Pretraining Using Adaptive Gradient Surgery in Computational Cytology

<div class="paper-toolbar">
  <div class="toolbar-left">
    <a href="https://arxiv.org/abs/2511.14639" target="_blank" class="toolbar-btn">arXiv: 2511.14639v1</a>
    <a href="https://arxiv.org/pdf/2511.14639.pdf" target="_blank" class="toolbar-btn">PDF</a>
  </div>
  <div class="toolbar-right">
    <button class="toolbar-btn favorite-btn" data-arxiv-id="2511.14639v1" 
            onclick="toggleFavorite(this, '2511.14639v1', 'SLAM-AGS: Slide-Label Aware Multi-Task Pretraining Using Adaptive Gradient Surgery in Computational Cytology')" title="Êî∂Ëóè">
      ‚òÜ Êî∂Ëóè
    </button>
    <button class="toolbar-btn share-btn" onclick="copyLink()" title="Â§çÂà∂ÈìæÊé•">
      üîó ÂàÜ‰∫´
    </button>
  </div>
</div>


**‰ΩúËÄÖ**: Marco Acerbis, Swarnadip Chatterjee, Christophe Avenel, Joakim Lindblad

**ÂàÜÁ±ª**: cs.CV

**ÂèëÂ∏ÉÊó•Êúü**: 2025-11-18

**Â§áÊ≥®**: 5 pages, 2 figures, Submitted to ISBI2026

**üîó ‰ª£Á†Å/È°πÁõÆ**: [GITHUB](https://github.com/Ace95/SLAM-AGS)

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**SLAM-AGSÔºöËÆ°ÁÆóÁªÜËÉûÂ≠¶‰∏≠Âü∫‰∫éËá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÁöÑSlide-LabelÊÑüÁü•Â§ö‰ªªÂä°È¢ÑËÆ≠ÁªÉ**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰∏âÔºöÁ©∫Èó¥ÊÑüÁü• (Perception & SLAM)**

**ÂÖ≥ÈîÆËØç**: `ËÆ°ÁÆóÁªÜËÉûÂ≠¶` `Â§ö‰ªªÂä°Â≠¶‰π†` `Âº±ÁõëÁù£Â≠¶‰π†` `Ëá™ÁõëÁù£Â≠¶‰π†` `Ê¢ØÂ∫¶ÊâãÊúØ` `Â§öÁ§∫‰æãÂ≠¶‰π†` `È™®È´ìÁªÜËÉûÂ≠¶`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. ËÆ°ÁÆóÁªÜËÉûÂ≠¶‰∏≠ÔºåÂÆû‰æãÊ†áÁ≠æËé∑ÂèñÊàêÊú¨È´òÊòÇ‰∏îË¥®ÈáèÂ∑ÆÔºåÈò≥ÊÄßÊ†∑Êú¨ÊØî‰æãÊûÅ‰ΩéÔºåÈôêÂà∂‰∫ÜÊ®°ÂûãËÆ≠ÁªÉÊïàÊûú„ÄÇ
2. SLAM-AGSÊ°ÜÊû∂ÈÄöËøáËÅîÂêà‰ºòÂåñÂº±ÁõëÁù£Áõ∏‰ººÊÄßÂíåËá™ÁõëÁù£ÂØπÊØîÁõÆÊ†áÔºåÂπ∂‰ΩøÁî®Ëá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÁ®≥ÂÆöËÆ≠ÁªÉËøáÁ®ã„ÄÇ
3. ÂÆûÈ™åË°®ÊòéÔºåÂú®‰ΩéÈò≥ÊÄßÊ†∑Êú¨ÊØî‰æã‰∏ãÔºåSLAM-AGSÂú®ÂåÖÁ∫ßÂà´F1ÂàÜÊï∞ÂíåÈò≥ÊÄßÁªÜËÉûÊ£ÄÁ¥¢ÊñπÈù¢ÊòæËëó‰ºò‰∫éÂÖ∂‰ªñÈ¢ÑËÆ≠ÁªÉÊñπÊ≥ï„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

ËÆ°ÁÆóÁªÜËÉûÂ≠¶Èù¢‰∏¥‰∏§Â§ßÊåëÊàòÔºöi) ÂÆû‰æãÁ∫ßÂà´ÁöÑÊ†áÁ≠æ‰∏çÂèØÈù†‰∏îËé∑ÂèñÊàêÊú¨È´òÊòÇÔºåii) Èò≥ÊÄßÊ†∑Êú¨ÊØî‰æãÊûÅ‰Ωé„ÄÇÊàë‰ª¨ÊèêÂá∫‰∫ÜSLAM-AGSÔºå‰∏Ä‰∏™Slide-LabelÊÑüÁü•ÁöÑÂ§ö‰ªªÂä°È¢ÑËÆ≠ÁªÉÊ°ÜÊû∂ÔºåÂÆÉËÅîÂêà‰ºòÂåñ(i) slide-negative patches‰∏äÁöÑÂº±ÁõëÁù£Áõ∏‰ººÊÄßÁõÆÊ†áÂíå(ii) slide-positive patches‰∏äÁöÑËá™ÁõëÁù£ÂØπÊØîÁõÆÊ†áÔºå‰ªéËÄåÂú®‰∏ãÊ∏∏‰ªªÂä°‰∏≠Ëé∑ÂæóÊõ¥Âº∫ÁöÑÊÄßËÉΩ„ÄÇ‰∏∫‰∫ÜÁ®≥ÂÆöÂ≠¶‰π†ÔºåÊàë‰ª¨Â∫îÁî®Ëá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÊù•Ëß£ÂÜ≥ÂÜ≤Á™ÅÁöÑ‰ªªÂä°Ê¢ØÂ∫¶Âπ∂Èò≤Ê≠¢Ê®°ÂûãÂ¥©Ê∫É„ÄÇÊàë‰ª¨Â∞ÜÈ¢ÑËÆ≠ÁªÉÁöÑÁºñÁ†ÅÂô®ÈõÜÊàêÂà∞Âü∫‰∫éÊ≥®ÊÑèÂäõÁöÑÂ§öÁ§∫‰æãÂ≠¶‰π†ËÅöÂêàÂô®‰∏≠ÔºåÁî®‰∫éÂåÖÁ∫ßÂà´ÁöÑÈ¢ÑÊµãÂíåÂØπÂåÖ‰∏≠ÊúÄÂºÇÂ∏∏ÂÆû‰æãÁöÑÊ≥®ÊÑèÂºïÂØºÊ£ÄÁ¥¢„ÄÇÂú®‰∏Ä‰∏™ÂÖ¨ÂºÄÁöÑÈ™®È´ìÁªÜËÉûÂ≠¶Êï∞ÊçÆÈõÜ‰∏äÔºåÊ®°ÊãüÈò≥ÊÄßÊ†∑Êú¨ÊØî‰æã‰ªé10%ÈôçËá≥0.5%ÔºåSLAM-AGSÂú®ÂåÖÁ∫ßÂà´F1ÂàÜÊï∞ÂíåTop 400Èò≥ÊÄßÁªÜËÉûÊ£ÄÁ¥¢ÊñπÈù¢‰ºò‰∫éÂÖ∂‰ªñÈ¢ÑËÆ≠ÁªÉÊñπÊ≥ïÔºåÂ∞§ÂÖ∂ÊòØÂú®‰ΩéÈò≥ÊÄßÊ†∑Êú¨ÊØî‰æã‰∏ãÂ¢ûÁõäÊúÄÂ§ßÔºåË°®ÊòéËß£ÂÜ≥Ê¢ØÂ∫¶Âπ≤Êâ∞ËÉΩÂ§üÂÆûÁé∞Á®≥ÂÆöÁöÑÈ¢ÑËÆ≠ÁªÉÂπ∂Âú®‰∏ãÊ∏∏‰ªªÂä°‰∏≠Ëé∑ÂæóÊõ¥Â•ΩÁöÑÊÄßËÉΩ„ÄÇ‰∏∫‰∫ÜÊñπ‰æøÈáçÁé∞ÔºåÊàë‰ª¨‰ª•ÂºÄÊ∫êÂΩ¢ÂºèÂàÜ‰∫´‰∫ÜÂÆåÊï¥ÁöÑÂÆûÁé∞ÂíåËØÑ‰º∞Ê°ÜÊû∂Ôºöhttps://github.com/Ace95/SLAM-AGS„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöËÆ°ÁÆóÁªÜËÉûÂ≠¶‰∏≠ÔºåÁªÜËÉûÂõæÂÉèÁöÑÂÆû‰æãÁ∫ßÂà´Ê†áÊ≥®ÊàêÊú¨È´òÊòÇ‰∏îË¥®ÈáèÈöæ‰ª•‰øùËØÅÔºåÂêåÊó∂Èò≥ÊÄßÁªÜËÉûÁöÑÊØî‰æãÈÄöÂ∏∏ÊûÅ‰ΩéÔºåËøôÁªôÊ®°ÂûãÁöÑËÆ≠ÁªÉÂ∏¶Êù•‰∫ÜÊûÅÂ§ßÁöÑÊåëÊàò„ÄÇÁé∞ÊúâÁöÑÊñπÊ≥ïÈöæ‰ª•ÊúâÊïàÂà©Áî®ÊúâÈôêÁöÑÊ†áÊ≥®‰ø°ÊÅØÔºåÂπ∂‰∏îÂÆπÊòìÂèóÂà∞Á±ªÂà´‰∏çÂπ≥Ë°°ÁöÑÂΩ±ÂìçÔºåÂØºËá¥Ê®°ÂûãÊÄßËÉΩ‰∏ç‰Ω≥„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöSLAM-AGSÁöÑÊ†∏ÂøÉÊÄùË∑ØÊòØÂà©Áî®slide-levelÁöÑÂº±Ê†áÁ≠æ‰ø°ÊÅØÔºåÈÄöËøáÂ§ö‰ªªÂä°Â≠¶‰π†ÁöÑÊñπÂºèÔºåÂêåÊó∂Â≠¶‰π†slide-negative patchesÁöÑÁõ∏‰ººÊÄßÂíåslide-positive patchesÁöÑÂØπÊØîÁâπÂæÅ„ÄÇÈÄöËøáËøôÁßçÊñπÂºèÔºåÊ®°ÂûãÂèØ‰ª•Êõ¥Â•ΩÂú∞Âà©Áî®ÊúâÈôêÁöÑÊ†áÊ≥®‰ø°ÊÅØÔºåÂπ∂‰∏îËÉΩÂ§üÂ≠¶‰π†Âà∞Êõ¥È≤ÅÊ£íÁöÑÁâπÂæÅË°®Á§∫„ÄÇÊ≠§Â§ñÔºå‰∏∫‰∫ÜËß£ÂÜ≥Â§ö‰ªªÂä°Â≠¶‰π†‰∏≠Ê¢ØÂ∫¶ÂÜ≤Á™ÅÁöÑÈóÆÈ¢òÔºåÂºïÂÖ•‰∫ÜËá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÔºå‰ªéËÄåÁ®≥ÂÆöËÆ≠ÁªÉËøáÁ®ã„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöSLAM-AGSÁöÑÊï¥‰ΩìÊ°ÜÊû∂ÂåÖÊã¨‰∏â‰∏™‰∏ªË¶ÅÈÉ®ÂàÜÔºöÈ¢ÑËÆ≠ÁªÉÈò∂ÊÆµ„ÄÅÂ§öÁ§∫‰æãÂ≠¶‰π†ËÅöÂêàÈò∂ÊÆµÂíåÊ£ÄÁ¥¢Èò∂ÊÆµ„ÄÇÂú®È¢ÑËÆ≠ÁªÉÈò∂ÊÆµÔºå‰ΩøÁî®slide-levelÁöÑÂº±Ê†áÁ≠æ‰ø°ÊÅØÔºåÈÄöËøáÂ§ö‰ªªÂä°Â≠¶‰π†ÁöÑÊñπÂºèÔºåÂêåÊó∂Â≠¶‰π†slide-negative patchesÁöÑÁõ∏‰ººÊÄßÂíåslide-positive patchesÁöÑÂØπÊØîÁâπÂæÅ„ÄÇÂú®Â§öÁ§∫‰æãÂ≠¶‰π†ËÅöÂêàÈò∂ÊÆµÔºåÂ∞ÜÈ¢ÑËÆ≠ÁªÉÁöÑÁºñÁ†ÅÂô®ÈõÜÊàêÂà∞Âü∫‰∫éÊ≥®ÊÑèÂäõÁöÑÂ§öÁ§∫‰æãÂ≠¶‰π†ËÅöÂêàÂô®‰∏≠ÔºåÁî®‰∫éÂåÖÁ∫ßÂà´ÁöÑÈ¢ÑÊµã„ÄÇÂú®Ê£ÄÁ¥¢Èò∂ÊÆµÔºåÂà©Áî®Ê≥®ÊÑèÂäõÊú∫Âà∂ÂºïÂØºÊ£ÄÁ¥¢ÂåÖ‰∏≠ÊúÄÂºÇÂ∏∏ÁöÑÂÆû‰æã„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöSLAM-AGSÁöÑÂÖ≥ÈîÆÂàõÊñ∞Âú®‰∫é‰ª•‰∏ãÂá†‰∏™ÊñπÈù¢Ôºö1) ÊèêÂá∫‰∫ÜSlide-LabelÊÑüÁü•ÁöÑÂ§ö‰ªªÂä°È¢ÑËÆ≠ÁªÉÊ°ÜÊû∂ÔºåËÉΩÂ§üÊúâÊïàÂà©Áî®slide-levelÁöÑÂº±Ê†áÁ≠æ‰ø°ÊÅØ„ÄÇ2) ÂºïÂÖ•‰∫ÜËá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÔºåËß£ÂÜ≥‰∫ÜÂ§ö‰ªªÂä°Â≠¶‰π†‰∏≠Ê¢ØÂ∫¶ÂÜ≤Á™ÅÁöÑÈóÆÈ¢òÔºå‰ªéËÄåÁ®≥ÂÆöËÆ≠ÁªÉËøáÁ®ã„ÄÇ3) Â∞ÜÈ¢ÑËÆ≠ÁªÉÁöÑÁºñÁ†ÅÂô®ÈõÜÊàêÂà∞Âü∫‰∫éÊ≥®ÊÑèÂäõÁöÑÂ§öÁ§∫‰æãÂ≠¶‰π†ËÅöÂêàÂô®‰∏≠ÔºåÁî®‰∫éÂåÖÁ∫ßÂà´ÁöÑÈ¢ÑÊµãÂíåÂºÇÂ∏∏ÂÆû‰æãÊ£ÄÁ¥¢„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**ÔºöÂú®Â§ö‰ªªÂä°Â≠¶‰π†‰∏≠Ôºå‰ΩøÁî®‰∫ÜÂº±ÁõëÁù£Áõ∏‰ººÊÄßÊçüÂ§±ÂíåËá™ÁõëÁù£ÂØπÊØîÊçüÂ§±„ÄÇÂº±ÁõëÁù£Áõ∏‰ººÊÄßÊçüÂ§±Áî®‰∫éÂ≠¶‰π†slide-negative patchesÁöÑÁõ∏‰ººÊÄßÔºåËá™ÁõëÁù£ÂØπÊØîÊçüÂ§±Áî®‰∫éÂ≠¶‰π†slide-positive patchesÁöÑÂØπÊØîÁâπÂæÅ„ÄÇËá™ÈÄÇÂ∫îÊ¢ØÂ∫¶ÊâãÊúØÈÄöËøáÂä®ÊÄÅË∞ÉÊï¥ÊØè‰∏™‰ªªÂä°ÁöÑÊ¢ØÂ∫¶ÊñπÂêëÔºå‰ªéËÄåËß£ÂÜ≥Ê¢ØÂ∫¶ÂÜ≤Á™ÅÁöÑÈóÆÈ¢ò„ÄÇÊ≥®ÊÑèÂäõÊú∫Âà∂Áî®‰∫éÂ≠¶‰π†ÊØè‰∏™ÂÆû‰æãÁöÑÈáçË¶ÅÊÄßÔºå‰ªéËÄåÂÆûÁé∞ÂåÖÁ∫ßÂà´ÁöÑÈ¢ÑÊµãÂíåÂºÇÂ∏∏ÂÆû‰æãÊ£ÄÁ¥¢„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

Âú®È™®È´ìÁªÜËÉûÂ≠¶Êï∞ÊçÆÈõÜ‰∏äÔºåSLAM-AGSÂú®‰ΩéÈò≥ÊÄßÊ†∑Êú¨ÊØî‰æãÔºà0.5%-10%Ôºâ‰∏ãÔºåÊòæËëóÊèêÂçá‰∫ÜÂåÖÁ∫ßÂà´F1ÂàÜÊï∞ÂíåTop 400Èò≥ÊÄßÁªÜËÉûÊ£ÄÁ¥¢ÊÄßËÉΩÔºåË∂ÖË∂ä‰∫ÜÂÖ∂‰ªñÈ¢ÑËÆ≠ÁªÉÊñπÊ≥ï„ÄÇ‰æãÂ¶ÇÔºåÂú®0.5%Èò≥ÊÄßÊ†∑Êú¨ÊØî‰æã‰∏ãÔºåF1ÂàÜÊï∞ÊèêÂçáË∂ÖËøá5%ÔºåË°®ÊòéËØ•ÊñπÊ≥ïÂú®Êï∞ÊçÆÁ®ÄÁº∫Âú∫ÊôØ‰∏ãÁöÑÊúâÊïàÊÄß„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

SLAM-AGSÂú®ËÆ°ÁÆóÁªÜËÉûÂ≠¶È¢ÜÂüüÂÖ∑ÊúâÂπøÊ≥õÁöÑÂ∫îÁî®ÂâçÊôØÔºåÂèØÁî®‰∫éËæÖÂä©ËØäÊñ≠Ë°ÄÊ∂≤ËÇøÁò§„ÄÅÊÑüÊüìÊÄßÁñæÁóÖÁ≠â„ÄÇËØ•ÊñπÊ≥ïËÉΩÂ§üÊúâÊïàÂà©Áî®ÊúâÈôêÁöÑÊ†áÊ≥®‰ø°ÊÅØÔºåÊèêÈ´òËØäÊñ≠ÊïàÁéáÂíåÂáÜÁ°ÆÊÄßÔºåÈôç‰ΩéËØäÊñ≠ÊàêÊú¨„ÄÇÊú™Êù•ÔºåËØ•ÊñπÊ≥ïÊúâÊúõÊé®ÂπøÂà∞ÂÖ∂‰ªñÂåªÂ≠¶ÂõæÂÉèÂàÜÊûêÈ¢ÜÂüüÔºå‰æãÂ¶ÇÁóÖÁêÜÂõæÂÉèÂàÜÊûê„ÄÅÊîæÂ∞ÑÂΩ±ÂÉèÂàÜÊûêÁ≠â„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Computational cytology faces two major challenges: i) instance-level labels are unreliable and prohibitively costly to obtain, ii) witness rates are extremely low. We propose SLAM-AGS, a Slide-Label-Aware Multitask pretraining framework that jointly optimizes (i) a weakly supervised similarity objective on slide-negative patches and (ii) a self-supervised contrastive objective on slide-positive patches, yielding stronger performance on downstream tasks. To stabilize learning, we apply Adaptive Gradient Surgery to tackle conflicting task gradients and prevent model collapse. We integrate the pretrained encoder into an attention-based Multiple Instance Learning aggregator for bag-level prediction and attention-guided retrieval of the most abnormal instances in a bag. On a publicly available bone-marrow cytology dataset, with simulated witness rates from 10% down to 0.5%, SLAM-AGS improves bag-level F1-Score and Top 400 positive cell retrieval over other pretraining methods, with the largest gains at low witness rates, showing that resolving gradient interference enables stable pretraining and better performance on downstream tasks. To facilitate reproducibility, we share our complete implementation and evaluation framework as open source: https://github.com/Ace95/SLAM-AGS.

